Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep964 | Thyroid | ECE2022

Therapeutic approach to the diagnosis of Bethesda 5

Barrera-Martin Ana , Rosa Alhambra Exposito Mª , Moreno-Moreno Paloma , Angeles Galvez Moreno Maria

Introduction: Thyroid nodules are very common in the general population (20-75% ultrasound). There are clinical management criteria established by international societies and standardized cytological diagnostic criteria (Bethesda). However, there is still uncertainty in the management of category 5.Objectives: To evaluate the clinical attitude to the cytological diagnosis of Bethesda category 5 (B5) in thyroid fine-needle aspiration cytology (FNA). And s...

ea0063gp93 | Thyroid Nodules and Cancer | ECE2019

Tirads classification and final diagnosis of thyroid nodules classified as bethesda-3 after fine-needle aspiration

Rosa Alhambra Exposito Maria , Barrera Martin Ana , Segui Azpilcueta Pedro , Angeles Galvez Moreno Maria

Introduction: Ultrasound is the main diagnostic tool for imaging pathology of the thyroid gland. The TI-RADS classification allows the evaluation of a risk of malignancy in the case of thyroid nodules, indicating the need to perform a puncture for a histological study. Bethesda system classifies them according to the cytological malignancy risk. Bethesda category 3 (B3) comprises ‘follicular lesion of undetermined significance’ or ‘atypia of undetermined signifi...

ea0081p365 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Flash glucose monitoring in patients with DM3c

Rebollo-Roman Angel , Leon-Idougourram Soraya , Manuel Alzas Teomiro Carlos , Moreno-Moreno Paloma , Angeles Galvez Moreno Maria

Objective: Flash glucose monitoring (FGM) allows non-invasive glucose level assessment. Since November 2020 the use of this system is subsidized in patients with type 3c diabetes (DM3c) Our objective was to describe the characteristics of these patients and their glycemic control expressed as times in range.Methods and patients: Observational longitudinal clinical study between January 2021 and December 2021 in patients with DM3c in which FGM implementat...

ea0081p662 | Pituitary and Neuroendocrinology | ECE2022

Inferior petrosal sinus sampling for pituitary neuroendocrine tumors localization in cushing’s disease

Moreno-Moreno Paloma , Rosa Alhambra Exposito Ma , Rebollo-Roman Angel , Herrera-Martinez Aura D. , Angeles Galvez-Moreno Maria

Objective: Cushing’s disease (CD) is the most common cause of hypercortisolism after iatrogenic origin, it represents approximately 70% of patients with endogenous Cushing’s syndrome (CS) and ectopic ACTH secretion (10%). CD is caused by a corticotropin-secreting pituitary neuroendocrine tumor (ACTH-secreting Pit-NETs), 95% of cases as a microadenoma. In ACTH-dependent CS, differential diagnosis between CD and ectopic CS must be established. 40% of CD cases, any tumo...

ea0081ep693 | Pituitary and Neuroendocrinology | ECE2022

Influence of Desmopressin treatment in patients undergoing surgery for cushing’s disease

Moreno-Moreno Paloma , Rebollo-Roman Angel , Leon-Idougourram Soraya , Teomiro Carlos Manuel Alza s , Angeles Galvez-Moreno Maria

Objective: ACTH-secreting pituitary tumors (ACTHomas) express vasopressin (AVP) receptors. AVP receptors are also present in other types of cancer, exerting different effects on tumor growth depending on the receptor subtype. AVP type 1 receptors (V1a and V1b) are associated with stimulation of cell proliferation, AVP receptor type 2 (V2r) is associated with antiproliferative effects. Desmopressin (DAVP) is a synthetic analog of AVP that acts as a selective agonist for V2r, wh...

ea0090ep1130 | Late Breaking | ECE2023

Flash glucose monitoring in patients with DM3c

Rebollo-Roman Angel , Carmen Serrano Laguna Mª , Manuel Alzas Teomiro Carlos , Moreno-Moreno Paloma , Angeles Galvez Moreno Maria

Objective: Flash glucose monitoring (FGM) facilitates non-invasive glucose level assessment. Since November 2020 this system is subsidized in patients with type 3c diabetes (DM3c) Our objective was to describe the characteristics of these patients and their glycemic control expressed as times in range.Methods and patients: Observational longitudinal clinical study between January 2021 and January 2023 in patients with DM3c.Results:...

ea0041ep764 | Neuroendocrinology | ECE2016

Presence of adrenal lesions at diagnosis of cushing’s disease

Moreno-Moreno Paloma , Rosa Alhambra-Exposito Maria , Munoz-Jimenez Concepcion , Prior-Sanchez Inmaculada , Angeles Galvez-Moreno Maria

Objective: Patients with Cushing’s disease (CD) may have adrenal nodules or hyperplasia related chronic hyperstimulation by adrenocorticotropic hormone (ACTH). The aim of this study was to describe the prevalence of adrenal nodules or hyperplasia in patients with CD and their relation with ACTH levels at diagnosis.Patients and methods: Descriptive study of patients with CD (1995–2015). Variables analyzed: age, sex, body mass in...

ea0056p356 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Diabetes after liver transplantation

Moreno-Moreno Paloma , Barrera-Martin Ana , Munoz-Jimenez Concepcion , Rosa Alhambra-Exposito Maria , Angeles Galvez-Moreno Maria

Objective: Diagnosis of diabetes after transplantation (NODAT) has been described in up to 25% of cases. NODAT is a metabolically complex disorder, similar to type 2 diabetes. Factors that influence the development of NODAT are: BMI, HCV and immunosuppression. Objective: to know the prevalence and incidence of diabetes mellitus (DM) in liver transplant patients of our hospital.Patients and methods: Retrospective descriptive study of liver transplant pati...

ea0049ep1392 | Thyroid (non-cancer) | ECE2017

Is post-treatment whole body scan useful in differentiated thyroid cancer after thyroid ablation?

Prior-Sanchez Inmaculada , Rosa Alhambra Exposito Maria , Rebollo Roman Angel , Barrera Martin Ana , Moreno Ortega Estefania , Antonio Vallejo Casas Juan , Angeles Galvez Moreno Maria

Background: The short-term follow-up of patients with differentiated thyroid cancer (DTC) after the initial treatment is based on the measurement of stimulated thyroglobulin (s-Tg) and the use of diagnostic whole body scan (WBS).Objective: To evaluate the clinical utility of WBS performed at 6–12 months after thyroidectomy. Examine the correlation between s-Tg and results of WBS.Methods: We retrospectively evaluated all patien...

ea0041gp46 | Bone & Calcium Homeostasis (1) | ECE2016

Denosumab increases bone mineral density in primary hyperparathyroidism treated with cinacalcet

Munoz Jimenez Concepcion , Manuel Quesada Gomez Jose , Moreno Moreno, Maria Rosa Alhambra Exposito Paloma , Inmaculada Prior Sanchez Maria , Angeles Galvez Moreno Maria

Cinacalcet decreases and normalizes serum calcium levels across a broad severity range of primary hyperparathyroidism (PHPT), slightly reduces parathyroid hormone levels which generally remains elevated, whereas it has no effect on bone mineral density (BMD). Therefore, when administering cinacalcet to a patient with PHPT, concomitant treatment with an anti-catabolic drug should be considered.An open-labeled, prospective trial was conducted in 32 patient...